Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/08/2003CN1123358C Oral liquid for treating cerebrovascular disease
10/08/2003CN1123354C Medicine for treating pulmonary heart diseases
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/07/2003US6630514 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/07/2003US6630507 Cannabinoids as antioxidants and neuroprotectants
10/07/2003US6630506 Useful as antianginal agents, and cardioprotective agents and for treating peripheral vascular disease including intermittent claudication
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630502 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
10/07/2003US6630501 Phosphinic pseudo-peptides that may be used as matrix zinc metalloprotease inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630497 For therapy of hypertension and congestive heart failure; angiotensin II antagonist
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630178 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
10/07/2003US6630138 Protein C derivatives
10/07/2003US6630128 Insoluble support
10/07/2003US6629968 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
10/07/2003CA2373821C Topical compositions for prostaglandin e1 delivery
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2140890C Medicament for inhibiting neutrophil elastase and cathepsin g
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003080841A1 Calcineurin activators
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080643A1 Process for producing triterpene derivative
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080616A1 Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3
10/02/2003WO2003080609A1 Pyrazolopyrimidines derivatives
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080605A1 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
10/02/2003WO2003080603A1 Benzodiazepine derivative
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080592A1 2-pyrone compounds and use thereof
10/02/2003WO2003080583A1 Medicine for prevention and/or therapy of cardiomyopathy
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080181A2 Storage stable eplerenone formulation
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080104A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003WO2003080084A1 A process for the extraction of anthocyanins from black rice and composition thereof
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080063A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080057A1 Downsized core tablet containing nifedipine
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080047A1 Phosphate prodrugs of fluorooxindoles
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003080027A1 Nanoparticulate compositions of angiogenesis inhibitors
10/02/2003WO2003079998A2 Treatment of diseases involving defective gap junctional communication
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2003006950A3 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030188324 P300 transgenic animal
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187256 Benoxazinones/benzothiazinones as serine protease inhibitors
1 ... 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 ... 1595